The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Market Overview

• The microbial identification methods market has experienced significant growth.
• Market size: $4.74 billion in 2023.
• Projected growth: $5.09 billion in 2024 at a CAGR of 7.4%.
• Factors: Increase in infectious diseases, funding for diagnostics, infection control measures, food safety concerns, and demand for microbial identification.

Future Growth Projections

• Expected market size: $6.87 billion in 2028.
• CAGR: 7.8%.
• Drivers: Rapid microbiology testing, advancements in microbial studies, adoption of automated systems, rising disposable incomes, and government initiatives for food safety.
• Trends: New product launches, advancements in techniques, automated bacterial identification systems, microfluidics, robotics, nanotechnology, and strategic partnerships.

View More On The Microbial Identification Methods Market Report 2024 – https://www.thebusinessresearchcompany.com/report/microbial-identification-methods-global-market-report

Key Drivers and Trends

Role of Infectious Diseases

• Infectious diseases significantly impact market growth.
• Major diseases: HIV/AIDS, tuberculosis, malaria.
• Contributing factors: Antimicrobial resistance, climate change, population growth.
• Importance: Microbial identification methods are crucial for diagnosing, treating, and preventing infectious diseases.
• Example: UNAIDS reported over 39 million people with HIV in July 2023, up from 37.7 million in 2020.
• Example: CDC reported a 5.9% increase in tuberculosis cases in the US from 2021 to 2022.

Major Companies

• Key players: Merck KGaA, Sumitomo Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, GE Healthcare, Avantor Inc., Eurofins Scientific SE, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., bioMerieux SA, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Beckman Coulter Inc., HiMedia Laboratories, Hardy Diagnostics, LuminUltra Technologies Ltd., Biolog Inc.

Innovations in Microbial Identification

• Companies focus on developing advanced solutions.
• Example: Bruker Corporation launched MALDI Biotyper IVD software in April 2023.
  • Features: Enhanced accuracy and speed, MALDI-TOF mass spectrometry technology, rapid identification within minutes, expanded databases, improved specificity and sensitivity.

Strategic Acquisitions

• Example: Biolog Inc. acquired MIDI Labs and MIDI, Inc. in January 2023.
  • Goal: Enhance microbial identification capabilities.
  • Integration: MIDI’s fatty acid methyl ester (FAME) analysis with Biolog’s phenotype-based systems.

Market Segmentation

By Method

• Genotypic
• Phenotypic
• Proteotypic

By Type

• Bacterial Identification System
• Microbial Enumeration System
• Bacterial Resistance Identification Systems
• Microbiology Analyzer
• Other Types

By End User

• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Food Testing Laboratories
• Other End-Users

Regional Insights

• North America was the largest region in the microbial identification methods market in 2023.

Request A Sample Of The Global Microbial Identification Methods Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16118&type=smp